ClinicalTrials.gov record
Completed Phase 3 Interventional

A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

ClinicalTrials.gov ID: NCT05394519

Public ClinicalTrials.gov record NCT05394519. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Cagrilintide s.c. 2.4 mg in Combination With Semaglutide s.c. 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity and Type 2 Diabetes

Study identification

NCT ID
NCT05394519
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,200 participants

Conditions and interventions

Interventions

  • Cagrilintide Drug
  • Placebo cagrilintide Drug
  • Placebo semaglutide Drug
  • Semaglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2023
Primary completion
Jan 27, 2025
Completion
Feb 2, 2025
Last update posted
Jan 27, 2026

2023 – 2025

United States locations

U.S. sites
49
U.S. states
22
U.S. cities
42
Facility City State ZIP Site status
John Muir Physicians Network Concord California 94520
Headlands Research California, LLC Escondido California 92025
Providence Medical Foundation Fullerton California 92835
St. Jos Heritage Hlthcr_Fllrtn Fullerton California 92835
Diabetes/Lipid Mgmt & Res Ctr Huntington Beach California 92648
Clinical Trials Research Lincoln California 95648
Velocity Clin Res Los Angeles Los Angeles California 90017
Velocity Clin Res Wstlke Los Angeles California 90057
Desert Oasis Hlthcr Med Group Palm Springs California 92262
Diablo Clinical Research, Inc. Walnut Creek California 94598
New West Physicians,Inc. Golden Colorado 80401
Clinical Res Of W Florida Inc Clearwater Florida 33765
Northeast Research Institute Fleming Island Florida 32003
Jacksonville Ctr For Clin Res Jacksonville Florida 32216
Renstar Medical Research Ocala Florida 34470
AdventHealth Diab Inst Orlando Florida 32804
Florida Institute for Clinical Research, LLC Orlando Florida 32825
Oviedo Medical Research, LLC Oviedo Florida 32765
Endo Res Solutions Inc Roswell Georgia 30076
East West Med Res Inst Honolulu Hawaii 96814
Cedar-Crosse Research Center Chicago Illinois 60607
Iowa Diab & Endo Res Center West Des Moines Iowa 50266
Cotton-Oneill Diabetes and End Topeka Kansas 66606-2806
L-MARC Research Center Louisville Kentucky 40213
Pennington Biom Res Ctr Baton Rouge Louisiana 70808
Northern Pines Hlth Ctr, PC Buckley Michigan 49620
International Diabetes Center Minneapolis Minnesota 55416
StudyMetrix Research LLC City of Saint Peters Missouri 63303
Mercury Str Med Grp, PLLC Butte Montana 59701
AMC Community Endocrinology Albany New York 12203
Southgate Medical Group, LLP West Seneca New York 14224
Great Lakes Medical Research Westfield New York 14787
PharmQuest Life Sciences LLC Greensboro North Carolina 27408
Hillcrest Clinical Research Simpsonville South Carolina 29681-1538
Holston Medical Group Kingsport Tennessee 37660
Amarillo Med Spec LLP Amarillo Texas 79106
Texas Diab & Endo, P.A. Austin Texas 78731
Texas Diab & Endo, P.A. Austin Texas 78749
Velocity Clinical Res-Dallas Dallas Texas 75230
North Texas Endocrine Center Dallas Texas 75231
UT Southwestern Med Cntr Dallas Texas 75390-9302
PlanIt Research, PLLC Houston Texas 77079
DCOL Ctr for Clin Res Longview Texas 75605
Consano Clinical Research, LLC Shavano Park Texas 78231
Chrysalis Clinical Research St. George Utah 84790
National Clin Res Inc. Richmond Virginia 23294
Selma Medical Associates Winchester Virginia 22601-3834
Amherst Family Practice P.C. Winchester Virginia 22601
Capital Clin Res Ctr,LLC Olympia Washington 98502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 130 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05394519, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2026 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05394519 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →